Augmedix, Inc. (AUGX)

Augmedix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	28.22	46.22	21.25	41.26	20.76	9.6
Cash & Short-Term Investments	28.22	46.22	21.25	41.26	20.76	9.6
Cash Growth	14.94%	117.48%	-48.49%	98.70%	116.20%	-3.14%
Receivables	9.25	8.57	6.35	7.18	2.69	2.29
Prepaid Expenses	2.01	1.91	1.82	2	1.1	0.46
Restricted Cash	-	0.13	0.13	0.13	2.21	2
Other Current Assets	0.44	-	-	0.2	-	-
Total Current Assets	39.93	56.82	29.55	50.76	26.77	14.35
Property, Plant & Equipment	7.76	8.96	3.14	0.98	0.99	1.21
Other Long-Term Assets	5.88	0.93	0.95	0.33	0.17	0.17
Total Assets	53.67	66.71	33.64	52.07	27.94	15.74

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	0.88	0.72	1.56	1.37	0.26	0.64
Accrued Expenses	5.44	5.3	4.45	3.44	2.53	1.79
Current Portion of Long-Term Debt	5	5	3.75	1.5	6.61	2.89
Current Portion of Leases	1.43	1.49	0.87	-	-	-
Current Unearned Revenue	8.9	8.96	7.25	6.24	5.44	5.51
Other Current Liabilities	2.34	2.14	1.43	1.45	1.63	2.03
Total Current Liabilities	24	23.62	19.31	13.99	16.47	12.86
Long-Term Debt	15.54	15.3	11.38	13.34	8.34	9.72
Long-Term Leases	3.3	4.05	0.97	-	-	-
Other Long-Term Liabilities	0.36	0.42	0.51	0.67	-	0.02
Total Liabilities	43.2	43.39	32.18	28	24.81	22.61

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	171.48	169.2	127.69	125.48	87.05	3.17
Retained Earnings	-159.91	-144.96	-125.79	-101.34	-83.88	-68.27
Comprehensive Income & Other	-1.1	-0.92	-0.44	-0.07	-0.05	-0.04
Total Common Equity	10.47	23.32	1.47	24.07	3.12	-65.14
Shareholders' Equity	10.47	23.32	1.47	24.07	3.12	-6.87
Total Liabilities & Equity	53.67	66.71	33.64	52.07	27.94	15.74

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	25.28	25.85	16.97	14.84	14.95	12.62
Net Cash (Debt)	2.95	20.37	4.28	26.42	5.81	-3.01
Net Cash Growth	314.20%	376.29%	-83.81%	354.62%	-	-
Net Cash Per Share	0.06	0.46	0.11	0.91	0.83	-3.62
Filing Date Shares Outstanding	49.24	48.74	37.52	37.39	26.86	26.8
Total Common Shares Outstanding	49.08	48.61	37.44	37.39	26.86	1.98
Working Capital	15.93	33.21	10.24	36.77	10.3	1.49
Book Value Per Share	0.21	0.48	0.04	0.64	0.12	-32.89
Tangible Book Value	10.47	23.32	1.47	24.07	3.12	-65.14
Tangible Book Value Per Share	0.21	0.48	0.04	0.64	0.12	-32.89
Machinery	5.42	5.42	7.3	6.29	5.83	5.3
Construction In Progress	0.01	0.39	0.16	-	-	-
Leasehold Improvements	0.92	0.72	0.46	0.51	2.19	2.07

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error